WEDNESDAY, Nov. 6 (HealthDay News) -- A new study suggests that
only a quarter of people with hepatitis C are willing to start the
standard treatment for the serious viral infection.
When interferon injections -- the current standard treatment --
work, which only happens about 16 percent of the time, the risk of
dying drops by 45 percent, the University of Southern California
researchers said. Unfortunately, the drug doesn't always manage to
suppress the virus completely and many people can't tolerate its
side effects, which include gastrointestinal problems and
"This study points out the inadequacies of old therapies for hepatitis C," said Dr. Douglas Dieterich, a professor of medicine and liver diseases at the Icahn School of Medicine at Mount Sinai Hospital in New York City.
Hepatitis C is a viral infection that causes inflammation of the
liver. It's transmitted from person to person via blood.
Liver specialists said that although this study may be
reflective of what's currently going on in hepatitis C treatment,
soon there will be a huge shift in the way the disease is
"There's a revolution afoot in the treatment of hepatitis C," Dieterich said. He said new treatments that are taken in pill form should be approved in the coming months, and the newer medications will be far more effective at treating hepatitis C than interferon. He added that the treatment times also will be shorter.
"By the fourth quarter of next year, we'll have at least two new drug cocktails, curing upwards of 90 percent of patients -- even those with cirrhosis," he said.
Dr. David Bernstein, chief of the division of hepatology at
North Shore University Hospital in Manhasset, N.Y., said the new
treatment options are "exciting, but we need to remain somewhat
skeptical because many of the studies were done on small
Most people who have hepatitis C don't have any symptoms, and
can go years without knowing they have the virus.
"The bulk of people with hepatitis C were born between 1945 and 1965, and more than three-quarters of those infected don't know they have it," said Dr. Paul Gaglio, medical director of the Montefiore Einstein Center for Transplantation, in New York City.
The current study included more than 360,000 U.S. military
veterans who'd been diagnosed with hepatitis C. Ninety-seven
percent were male, and their average age was 52. More than half
were white and almost one-third were black.
Only 24 percent of the veterans chose to receive treatment for
their hepatitis C. Of those who received treatment, just 16.4
percent achieved undetectable levels of the virus in their blood.
That likely means that many of the study volunteers may have
stopped taking the medication before the recommended 48 weeks of
treatment was finished, Bernstein said.
The good news was that when the treatment did work, the risk of
dying from any cause dropped by 45 percent.
"This study is indicative of standard practice now," Gaglio said. "Patients don't want to take the treatment because there are lots of side effects. But big changes are coming."
Bernstein said three new treatment regimens likely will be
approved by the U.S. Food and Drug Administration in December, and
another round of approvals likely will occur in late 2014 or early
All three experts said the message for people with hepatitis C
is to go back to their doctor and get re-evaluated. New treatment
options will soon be available, and they'll be available for folks
with kidney disease and cirrhosis of the liver.
"The treatment world is really changing," Bernstein said.
Gaglio added that if you were born between 1945 and 1965 and you
haven't been tested for hepatitis C, it's important to get tested
to ensure that you aren't infected with the virus.
The study was published online Nov. 5 in the journal
JAMA Internal Medicine.
Learn more about hepatitis C from the
U.S. National Library of Medicine.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.